Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways
Cites (212)
Items 201–209 of 209
- Pharmacogenetics and Pharmagenomics, Trends in Normal and Pathological Aging Studies: Focus on p53Cristina Lanni, Marco Racchi, Daniela Letizia Uberti, Giuliano Mazzini, Serena Stanga, Elena Sinforiani, Maurizio Memo, Stefano M. Govoni · 2008 · Current Pharmaceutical Design
- Cancer in the Aged: An Autopsy Study of 940 Cancer PatientsToshiharu Ishii, Kohtaro MAEDA, Kaoru Nakamura, Y Hosoda · 1979 · Journal of the American Geriatrics Society
- AD and cancerCatherine M. Roe, María Isabel Behrens · 2013 · Neurology
- Estimating Exposure to Pesticides in Epidemiological Studies of CancerAaron E. Blair, Shelia Hoar Zahm, Kenneth P. Cantor, Patricia Ann Stewart · 1988 · ACS symposium series
- The Multiple Roles of Peptidyl Prolyl Isomerases in Brain CancerStefano Stifani · 2018 · Biomolecules
- Report of ten years’ activity in an Alzheimer’s disease assessment unitElena Sinforiani, Chiara Zucchella, Chiara Pasotti, Michelangelo Bartolo, Giuseppe Nappi · 2009 · Aging Clinical and Experimental Research
- The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's DiseaseLarson, Megan, Sherman, Mathew A, Fatou Amar, Mario Nuvolone, Schneider, Julie A, Bennett, David A, Adriano Aguzzi, Sylvain Lesné · 2012 · Zurich Open Repository and Archive (University of Zurich)
- PIN1 promoter polymorphism (−842 G>C) contributes to a decreased risk of cancer: Evidence from meta-analysisLiangjun Tao, YI-SHENG CHEN, Lei Yao, BIN ZOU, Lingsong Tao, JIAN KONG, YING-QING LIU, Qiang Cao, Changjun Yin · 2014 · Oncology Letters
- Untitled workRasheed · 1974 · 10.1002/1097-0142(197404)33:4